Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Prednisone in Cardiac Sarcoidosis
NCT03593759Phase 3Recruiting
- Sponsor
- University of Ottawa Heart Institute
- Start
- Jan 2019
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of methotrexate in cardiac sarcoidosis (CS), sponsored by University of Ottawa Heart Institute. Started Jan 2019; status: recruiting.
02
Drugs
methotrexate
03
Conditions
cardiac sarcoidosis (CS)
Beyond the preview
Go deeper on NCT03593759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593759.